Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma

被引:10
作者
Crump, Michael [1 ]
Herst, Jordan [2 ]
Baldassarre, Fulvia [3 ]
Sussman, Jonathan [4 ]
MacEachern, Janet [5 ]
Hodgson, David [1 ]
Cheung, Matthew C. [6 ]
机构
[1] Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada
[2] Northeastern Ontario Reg Canc Ctr, Sudbury, ON, Canada
[3] McMaster Univ, Dept Oncol, Canc Care Ontario, Program Evidence Based Care, Hamilton, ON, Canada
[4] Juravinski Canc Ctr, Hamilton, ON, Canada
[5] Grand River Reg Canc Ctr, Kitchener, ON, Canada
[6] Odette Canc Ctr, Toronto, ON, Canada
关键词
INVOLVED-FIELD RADIOTHERAPY; BREAST-CANCER RISK; HEMATOPOIETIC-CELL TRANSPLANTATION; COMBINED-MODALITY THERAPY; RANDOMIZED-TRIALS; CYCLES; CHEMOTHERAPY; DISEASE; SURVIVORS; ABVD;
D O I
10.1182/blood-2014-08-545152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Case 1. Anne is a 23-year-old nursing student who presents with bilateral cervical, left supraclavicular, and left axillary adenopathy. Computed tomography (CT) scan of the thorax reveals a 6-cm anterior mediastinal mass. Biopsy of the left supraclavicular lymph node reveals classical nodular sclerosis Hodgkin lymphoma. A complete blood count is normal and the erythrocyte sedimentation rate (ESR) is 25 mm/h. CT scan of the abdomen/pelvis show normal liver and spleen and no evidence of abdominal lymphadenopathy. You are asked to advise her on the role of radiation therapy in her treatment plan. Case 2. John is a 48-year-old teacher who presents with chest pain following a hockey game. A chest radiograph reveals mediastinal widening, and a contrast-enhancedCT scan shows a 7.5-cm anterior mediastinalmass, with enlarged paratracheal and right hilar lymph nodes. Image-guided core biopsy of the mediastinal mass is diagnostic for classical Hodgkin lymphoma. The hemoglobin is 130 g/L, white blood cell count and platelets are normal, and the ESR is 35 mm/h. John asks you about the role of radiotherapy in the management of his lymphoma. © 2015 by The American Society of Hematology.
引用
收藏
页码:1708 / 1716
页数:9
相关论文
共 42 条
[1]   Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors-Retrospective cohort analyses and a concept for prospective intervention [J].
Andersson, Anne ;
Naslund, Ulf ;
Tavelin, Bjorn ;
Enblad, Gunilla ;
Gustavsson, Anita ;
Malmer, Beatrice .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (08) :1914-1917
[2]   Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French "ATU" program) by the French Intergroup of Myeloproliferative Neoplasms (FIM) [J].
Andreoli, Annalisa ;
Rey, Jerome ;
Dauriac, Charles ;
Herbrecht, Raoul ;
Nicolini, Franck E. ;
Recher, Christian ;
Rousselot, Philippe ;
Delaunay, Jacques ;
Drenou, Bernard ;
Ranta, Dana ;
Legros, Laurence ;
Delain, Martine ;
Cony-Makhoul, Pascale ;
Viallard, Jean-Francois ;
Visanica, Sorin ;
Lefort, Sophie ;
Dupriez, Brigitte ;
Coiteux, Valerie ;
Guyotat, Denis ;
Slama, Borhane ;
Benabed, Khaled ;
Demory, Jean-Loup ;
Giraudier, Stephane ;
Roos-Weil, Damien ;
Sanhes, Laurence ;
Quinquenel, Anne ;
Lenain, Pascal ;
Ugo, Valerie ;
Kiladjian, Jean-Jacques ;
Roy, Lydia .
BLOOD, 2012, 120 (21)
[3]   Reduced Versus Full Doses of Irradiation After 3 Cycles of Combined Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in Early Stage Hodgkin Lymphomas Results of a Randomized Trial [J].
Arakelyan, Nina ;
Jais, Jean-Philippe ;
Delwail, Vincent ;
Briere, Josette ;
Moles-Moreau, Marie-Pierre ;
Senecal, Delphine ;
Berthou, Christian ;
Desablens, Bernard ;
Colonna, Pierre ;
Andrieu, Jean-Marie .
CANCER, 2010, 116 (17) :4054-4062
[4]   Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study [J].
Bhatia, S ;
Robison, LL ;
Francisco, L ;
Carter, A ;
Liu, Y ;
Grant, M ;
Baker, KS ;
Fung, H ;
Gurney, JG ;
McGlave, PB ;
Nademanee, A ;
Ramsay, NKC ;
Stein, A ;
Weisdorf, DJ ;
Forman, SJ .
BLOOD, 2005, 105 (11) :4215-4222
[5]   ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results [J].
Bonadonna, G ;
Bonfante, V ;
Viviani, S ;
Di Russo, A ;
Villani, F ;
Valagussa, P .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2835-2841
[6]   THE PRACTICE GUIDELINES DEVELOPMENT CYCLE - A CONCEPTUAL TOOL FOR PRACTICE GUIDELINES DEVELOPMENT AND IMPLEMENTATION [J].
BROWMAN, GP ;
LEVINE, MN ;
MOHIDE, EA ;
HAYWARD, RSA ;
PRITCHARD, KI ;
GAFNI, A ;
LAUPACIS, A .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :502-512
[7]   Obinutuzumab (GA101) Plus CHOP Or FC In Relapsed/Refractory Follicular Lymphoma: Final Data From The Maintenance Phase Of The Phase 1b GAUDI Study (BO21000) [J].
Davies, Andrew ;
Radford, John ;
Cartron, Guillaume ;
Morschhauser, Franck ;
Salles, Gilles Andre ;
Marcus, Robert ;
Wenger, Michael K. ;
Lei, Guiyuan ;
Wassner-Fritsch, Elisabeth ;
Vitolo, Umberto .
BLOOD, 2013, 122 (21)
[8]   Breast Cancer Risk in Female Survivors of Hodgkin's Lymphoma: Lower Risk After Smaller Radiation Volumes [J].
De Bruin, Marie L. ;
Sparidans, Judith ;
van't Veer, Mars B. ;
Noordijk, Evert M. ;
Louwman, Marieke W. J. ;
Zijlstra, Josee M. ;
van den Berg, Hendrik ;
Russell, Nicola S. ;
Broeks, Annegien ;
Baaijens, Margreet H. A. ;
Aleman, Berthe M. P. ;
van Leeuwen, Flora E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4239-4246
[9]   The EORTC strategy in the treatment of Hodgkin's lymphoma [J].
Eghbali, H ;
Raemaekers, J ;
Carde, P .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 :135-140
[10]   Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial [J].
Eich, Hans Theodor ;
Diehl, Volker ;
Goergen, Helen ;
Pabst, Thomas ;
Markova, Jana ;
Debus, Juergen ;
Ho, Anthony ;
Doerken, Bernd ;
Rank, Andreas ;
Grosu, Anca-Ligia ;
Wiegel, Thomas ;
Karstens, Johann Hinrich ;
Greil, Richard ;
Willich, Normann ;
Schmidberger, Heinz ;
Doehner, Hartmut ;
Borchmann, Peter ;
Mueller-Hermelink, Hans-Konrad ;
Mueller, Rolf-Peter ;
Engert, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) :4199-4206